Morten Langgård

This inventor holds 47 USPTO granted patents and 5 published patent applications and 17 EPO patents, primarily in PDE Inhibitors. Top assignees: H. Lundbeck A/s, Other. Active years: 2012-2023.

USPTO Granted Patents = 47 (Patent Applications = 5)

% Patents Active = 57.4

EPO Patents = 17 (Patent Applications = 17)

Average Co-Inventor Count = 5.6

ph-index = 7

Forward Citations = 140(Granted Patents)

Location History:

Valby, DK (2018 - 2020)
Glostrup, DK (2012 - 2023)

Company Filing History:

46 out of 511

H. Lundbeck A/s

patents

1 out of 834,307

Other

patents

Years Active: 2012-2023

Loading Chart...

Areas of Expertise:

PDE1 Inhibitors

Pyrazolo Derivatives

Imidazopyrazinones

Quinazolin Compounds

PDE9 Inhibitors

PDE10A Enzyme Inhibitors

Combination Treatments

Hexahydrofuropyrroles

N-Substituted Phthalamic Acids

Heteroaromatic Phenylimidazole

47 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11851425 - Combination treatments comprising administration of 1H-pyrazolo[4,3-B]pyridines (2023-12-26),

2. 11634416 - Combination treatments comprising administration of 1H-pyrazolo[4,3-b]pyridines (2023-04-25),

3. 11535611 - Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors (2022-12-27),

4. 11491140 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors (2022-11-08),

5. 11472810 - Imidazopyrazinones as PDE1 inhibitors (2022-10-18),

6. 11104680 - 1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 inhibitors (2021-08-31),

7. 11026924 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors (2021-06-08),

8. 11026923 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors (2021-06-08),

9. 10912773 - Combinations comprising substituted imidazo[1,5-a]pyrazinones as PDE1 inhibitors (2021-02-09),

10. 10905688 - Combinations comprising substituted imidazo[1,5-α]pyrazinones as PDE1 inhibitors (2021-02-02),

11. 10858362 - Imidazopyrazinones as PDE1 inhibitors (2020-12-08),

12. 10806718 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors (2020-10-20),

13. 10766893 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors (2020-09-08),

14. 10689379 - Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors (2020-06-23),

15. 10633382 - Imidazopyrazinones, pyrazolopyrimidinones and pyrazolopyridinones as PDE1 inhibitors (2020-04-28),

Title: The Innovative Journey of Morten Langgård

Introduction: Morten Langgård, a talented inventor hailing from Glostrup, Denmark, has made significant contributions to the field of innovation with his creative mind and dedication to problem-solving.

Latest Patents: Morten Langgård's latest patents showcase his expertise in developing cutting-edge technologies in the medical device industry, focusing on improving patient outcomes and healthcare efficiency.

Career Highlights: Throughout his career, Morten Langgård has demonstrated a keen ability to translate ideas into tangible inventions that have the potential to impact lives positively. His innovative spirit and commitment to excellence have earned him recognition as a leading figure in the innovation landscape.

Collaborations: Morten Langgård has collaborated with various research institutions, universities, and companies to bring his inventions to life. His partnerships have been instrumental in advancing his ideas from concept to reality, showcasing his ability to work effectively in multidisciplinary teams.

Conclusion: Morten Langgård's journey as an inventor exemplifies the power of innovation in driving positive change. His relentless pursuit of excellence and passion for creating solutions to complex challenges continue to inspire the next generation of inventors and innovators worldwide.